A COMMON antidepressant is reportedly out of stock across the country.
The drug, which is available in different doses, is expected to be in short supply until later this year.
Venlafaxine 75mg immediate-release tablets is set to be unavailable across the country until November.
This comes after a Tier 2 medium-impact alert was issued by the Department of Health and Social Care (DHSC) warning of the short supply.
The shortage does not affect modified-release venlafaxine tablets, with 37.5mg, 75mg and 150mg capsules recommended to support the increased demand.
Prescribers of the medication have been told not to issue any new prescriptions of the 75mg tablet until the shortage has ended.
Read more Health News
CRISIS
NHS drug warning as 2 new meds used by millions face shortage – are you affected?
ALE-MENTS
How your favourite PINT could uncover bowel cancer – and when to see your doctor
This specific warning only relates to immediate-release venlafaxine tablets, which are prescribed to be taken twice a day, in comparison to the modified-release capsues which are only taken once.
Venlafaxine is a type of antidepressant called a selective noradrenaline reuptake inhibitor, or SNRI, mainly used to help treat depression.
It is thought to work by increasing seratonin and noradrenaline levels, which help to reduce stress and negative thoughts.
It can also be used to help with anxiety, panic attacks and menopause symptoms such as hot flushes in women with breast cancer.
Most read in Health
AISLE BE DAMNED
Worst ‘healthy’ baby food revealed – as 1 in 5 ‘putting health at risk’
CRISIS
NHS drug warning as 2 new meds used by millions face shortage – are you affected?
ALE-MENTS
How your favourite PINT could uncover bowel cancer – and when to see your doctor
SHOCK DIAGNOSIS
I spotted random bruises on my legs – now I don’t know how long I have left
Venlafaxine works differently to SSRIs, such as sertraline, fluoxetine and citalopram, which are prescribed much more frequently.
A copy of the supply notice has subsequently been sent to all NHS pharmacy email addresses.